Vivanza Biosciences board meeting scheduled for May 4, 2026 to approve audited standalone and consolidated financial results for Q4 and FY ending March 31, 2026.
The trading window for insiders remains closed until 48 hours after the declaration of the financial results as per SEBI insider trading regulations.
This intimation is made pursuant to SEBI LODR Regulations 29, 30, and 33 regarding corporate disclosures and board meeting announcements.